Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Apontis Pharma AG Director's Dealing 2024

May 14, 2024

725_dirs_2024-05-14_2f6ac01a-1d86-4b2b-9ca7-bea98e4f8b0d.html

Director's Dealing

Open in viewer

Opens in your device viewer

News Details

Directors’ Dealings | 14 May 2024 11:10

APONTIS PHARMA AG: Thomas Milz, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

14.05.2024 / 11:10 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name: Thomas
Last name(s): Milz

2. Reason for the notification

a) Position / status

Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

APONTIS PHARMA AG

b) LEI

894500ETO1J6MR8PDF91

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: DE000A3CMGM5

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s) Volume(s)
8.96 EUR 8,960.00 EUR

d) Aggregated information

Price Aggregated volume
8.9600 EUR 8,960.0000 EUR

e) Date of the transaction

2024-05-13; UTC+2

f) Place of the transaction

Name: Tradegate
MIC: TGAT

14.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: APONTIS PHARMA AG
Alfred-Nobel-Str. 10
40789 Monheim
Germany
Internet: https://apontis-pharma.de/
End of News EQS News Service

show this